Gilead Sciences (GILD) Could Outperform in 2H19 for 4 Reasons

July 12, 2019 8:22 AM EDT Send to a Friend
Oppenheimer analyst Hartaj Singh reiterated an Outperform rating and $85.00 price target on Gilead Sciences (NASDAQ: GILD) and believes shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login